海尔生物 (688139)
Qingdao Haier Biomedical Co., Ltd.
K-Line Chart
No K-line data available
Company NameQingdao Haier Biomedical Co., Ltd.
Listing Date2019-10-25
Issue Price15.53RMB
Registered Capital31649.292210k RMB
Legal RepresentativeLiu Zhanjie
Registered AddressNo. 280 Fengyuan Road, High-tech Zone, Qingdao City, Shandong Province
IndustryMedical Devices
Main BusinessThe company's main business originated from the R&D, production, and sales of biomedical low-temperature storage equipment, and it is a comprehensive biotechnology solution service provider based on IoT transformation. The company serves the global market, primarily providing low-temperature storage solutions for scenarios such as biobanks, drug and reagent safety, blood safety, and vaccine safety. It is a pioneer in integrating and innovating IoT technology, committed to providing comprehensive IoT biotechnology solutions addressing the pain points in the above scenarios.
Company ProfileHaier Biomedical, also known as Qingdao Haier Biomedical Co., Ltd., originated from the R&D, production, and sales of biomedical low-temperature storage equipment and is transforming into a comprehensive biotechnology solution service provider based on the Internet of Things (IoT). Serving the global market, Haier Biomedical primarily provides comprehensive low-temperature storage solutions for scenarios such as biobanks, blood safety, vaccine safety, and drug and reagent safety.
Addressing major national needs such as blood and vaccine safety, Haier Biomedical integrates and innovates IoT technology with biomedical low-temperature storage technology, pioneering the establishment of global IoT smart blood safety solutions and IoT smart vaccination solutions, striving to become a leader in comprehensive IoT biotechnology solutions.
To date, Haier Biomedical has provided biobank solutions to national-level major strategic support projects such as the China Marrow Donor Program, the National GeneBank, and the China Human Genetic Resources Bank, as well as key medical institutions including Shanghai Ruijin Hospital, Beijing 301 Hospital, and Sichuan West China Hospital. Its biobank solutions have been applied in over 500 biobanks, strongly supporting China's biotechnology research and innovation process.
Stock Details
1. Key Indicators
- Total Shares(W): 734059.07
- Circulating A-Shares(W): 734059.07
- Earnings Per Share(RMB): 1.23
- Net Assets Per Share(RMB): 5.67
- Operating Revenue(W RMB): 1345261.60
- Total Profit(W RMB): 1345261.60
- **Net Profit Attributable to Parent(W RMB) **: 1345261.60
- Net Profit Growth Rate(%): -55.89
- Weighted Return on Equity(%): 4.6500
- Operating Cash Flow Per Share(RMB): 1.23
- Undistributed Profit Per Share(RMB): 1.23
- Capital Reserve Per Share(RMB): 1.23
2. Main Business
The main business covers:
- New energy vehicle manufacturing and sales
- Intelligent transportation system R&D
- Fuel cell technology development
- Autonomous driving solutions
3. Company Basic Information
- Company Name: Dongfeng Motor Corporation Limited
- Listing Date: 2001-05-18
- Industry: Automobile Manufacturing
- Address: Economic and Technological Development Zone, Wuhan City, Hubei Province
- Website: https://www.dongfeng.com.cn/
- Company Profile: The company was established by Beijing Capital Venture Group as the main sponsor and approved by the State Economic and Trade Commission as a joint stock company initiated by the sponsor method. The company focuses on automobile manufacturing and related technology R&D, and is one of the important enterprises in China's automobile industry.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Securities Finance Co., Ltd. | National Team | 5000 | 10.2 |
| 2 | China Asset Management Co., Ltd. | Public Fund | 3200 | 6.5 |
| 3 | Hillhouse Capital | Private Equity Fund | 2800 | 5.7 |
| 4 | National Social Security Fund | National Team | 2500 | 5.1 |
| 5 | E Fund Management Co., Ltd. | Public Fund | 2000 | 4.1 |
| 6 | China Universal Asset Management Co., Ltd. | Public Fund | 1800 | 3.7 |
| 7 | CITIC Securities | Securities Company | 1500 | 3.1 |
| 8 | Guotai Junan Securities | Securities Company | 1200 | 2.4 |
| 9 | China Merchants Bank | Bank | 1000 | 2.0 |
| 10 | ICBC Credit Suisse Asset Management Co., Ltd. | Public Fund | 900 | 1.8 |
5. Concept Sectors
- Carbon Neutrality
- Intelligent Transportation
- Fuel Cell
- Autonomous Driving
- New Energy Vehicles
- Hydrogen Energy
- Huawei Auto
- Internet of Vehicles
Remarks
- Data update date: 2025-11-02
- Data source: Public market information